Accendra Health(ACH)
$0.15-0.01 (-3.97%)
ACH
Accendra Health financials statements
$0.15
At close:-0.01 (-3.97%)
Want to see ACH full AI Analyst Report?
Accendra Health (ACH) Ratios
569 Followers
Accendra Health Ratios
ACH's free cash flow for Q3 2026 was $36.00M. For the 2026 fiscal year, ACH's free cash flow was decreased by $-40.08M and operating cash flow was $-17.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.58 | 1.08 | 1.11 | 1.47 | 1.73 |
| Quick Ratio | 0.50 | 0.47 | 0.52 | 0.61 | 0.61 |
| Cash Ratio | 0.30 | 0.03 | 0.13 | 0.04 | 0.04 |
| Solvency Ratio | -0.30 | -0.02 | 0.06 | 0.06 | 0.12 |
| Operating Cash Flow Ratio | -0.11 | 0.09 | 0.39 | 0.21 | 0.09 |
| Short-Term Operating Cash Flow Coverage | -0.35 | 4.04 | 3.63 | 21.14 | 2.83 |
| Net Current Asset Value | $ -2.36B | $ -2.07B | $ -2.07B | $ -2.15B | $ -276.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.91 | 0.46 | 0.47 | 0.52 | 0.33 |
| Debt-to-Equity Ratio | -4.85 | 3.79 | 2.60 | 2.95 | 1.23 |
| Debt-to-Capital Ratio | 1.26 | 0.79 | 0.72 | 0.75 | 0.55 |
| Long-Term Debt-to-Capital Ratio | 1.33 | 0.76 | 0.67 | 0.72 | 0.50 |
| Financial Leverage Ratio | -5.32 | 8.24 | 5.51 | 5.70 | 3.77 |
| Debt Service Coverage Ratio | 0.55 | 0.25 | 1.12 | 2.63 | 3.92 |
| Interest Coverage Ratio | 2.07 | -1.44 | 0.66 | 1.11 | 7.66 |
| Debt to Market Cap | 10.05 | 1.84 | 35.69 | 42.73 | 7.74 |
| Interest Debt Per Share | 30.44 | 29.76 | 845.65 | 980.60 | 413.00 |
| Net Debt to EBITDA | 8.88 | 40.81 | 5.54 | 7.39 | 2.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 46.68% | 20.74% | 20.56% | 18.35% | 15.46% |
| EBIT Margin | 0.19% | -2.00% | 1.00% | 1.40% | 3.32% |
| EBITDA Margin | 7.96% | 0.48% | 3.78% | 3.70% | 4.25% |
| Operating Profit Margin | 8.03% | -1.94% | 1.01% | 1.44% | 3.77% |
| Pretax Profit Margin | -3.69% | -3.34% | -0.53% | 0.11% | 2.83% |
| Net Profit Margin | -39.85% | -3.39% | -0.40% | 0.22% | 2.26% |
| Continuous Operations Profit Margin | -3.72% | -3.39% | -0.40% | 0.22% | 2.26% |
| Net Income Per EBT | 1079.56% | 101.49% | 75.47% | 205.57% | 80.07% |
| EBT Per EBIT | -45.98% | 172.00% | -52.37% | 7.62% | 75.11% |
| Return on Assets (ROA) | -44.89% | -7.79% | -0.81% | 0.42% | 6.27% |
| Return on Equity (ROE) | 238.76% | -64.17% | -4.47% | 2.37% | 23.61% |
| Return on Capital Employed (ROCE) | 14.74% | -7.47% | 3.26% | 3.74% | 16.81% |
| Return on Invested Capital (ROIC) | 12.33% | -7.35% | 2.26% | 3.65% | 13.19% |
| Return on Tangible Assets | -101.24% | -11.98% | -1.34% | 0.69% | 7.63% |
| Earnings Yield | -511.19% | -36.16% | -70.70% | 38.47% | 175.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 28.80 | 15.50 | 17.27 | 13.04 | 14.36 |
| Payables Turnover | 4.05 | 6.77 | 7.00 | 7.08 | 8.26 |
| Inventory Turnover | 19.79 | 7.49 | 7.39 | 6.10 | 5.53 |
| Fixed Asset Turnover | 7.56 | 12.37 | 12.29 | 11.59 | 19.14 |
| Asset Turnover | 1.13 | 2.30 | 2.03 | 1.85 | 2.77 |
| Working Capital Turnover Ratio | -21.93 | 59.75 | 22.00 | 11.67 | 11.07 |
| Cash Conversion Cycle | -58.98 | 18.38 | 18.41 | 36.35 | 47.22 |
| Days of Sales Outstanding | 12.67 | 23.54 | 21.13 | 27.99 | 25.42 |
| Days of Inventory Outstanding | 18.45 | 48.71 | 49.38 | 59.88 | 66.01 |
| Days of Payables Outstanding | 90.11 | 53.88 | 52.11 | 51.52 | 44.21 |
| Operating Cycle | 31.12 | 72.25 | 70.51 | 87.87 | 91.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.32 | 2.10 | 244.35 | 109.07 | 42.68 |
| Free Cash Flow Per Share | -3.94 | -0.87 | 175.77 | 53.17 | 25.60 |
| Dividend Paid and CapEx Coverage Ratio | -0.51 | 0.71 | 3.56 | 1.95 | 2.46 |
| Capital Expenditure Coverage Ratio | -0.51 | 0.71 | 3.56 | 1.95 | 2.50 |
| Operating Cash Flow Coverage Ratio | -0.05 | 0.08 | 0.31 | 0.12 | 0.11 |
| Operating Cash Flow to Sales Ratio | -0.04 | 0.02 | 0.07 | 0.03 | 0.01 |
| Free Cash Flow Yield | -140.78% | -6.65% | 912.12% | 272.22% | 58.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.20 | -2.76 | -1.41 | 2.60 | 0.57 |
| Price-to-Sales (P/S) Ratio | 0.08 | 0.09 | 0.01 | 0.01 | 0.01 |
| Price-to-Book (P/B) Ratio | -0.47 | 1.77 | 0.06 | 0.06 | 0.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.71 | -15.04 | 0.11 | 0.37 | 1.70 |
| Price-to-Operating Cash Flow Ratio | -2.12 | 6.21 | 0.08 | 0.18 | 1.02 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.00 | 0.01 | -0.03 | 0.00 |
| Enterprise Value Multiple | 9.86 | 60.39 | 5.69 | 7.55 | 2.95 |
| Enterprise Value | 2.17B | 3.09B | 2.22B | 2.78B | 1.22B |
| EV to EBITDA | 9.86 | 60.39 | 5.69 | 7.55 | 2.95 |
| EV to Sales | 0.78 | 0.29 | 0.21 | 0.28 | 0.13 |
| EV to Free Cash Flow | -7.15 | -46.40 | 4.17 | 17.56 | 16.44 |
| EV to Operating Cash Flow | -21.29 | 19.15 | 3.00 | 8.56 | 9.86 |
| Tangible Book Value Per Share | -23.74 | -13.85 | -355.12 | -394.26 | 104.67 |
| Shareholders’ Equity Per Share | -5.99 | 7.37 | 304.86 | 317.33 | 322.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | 0.25 | -1.06 | 0.20 |
| Revenue Per Share | 35.92 | 139.44 | 3408.98 | 3340.94 | 3362.93 |
| Net Income Per Share | -14.31 | -4.73 | -13.62 | 7.51 | 76.15 |
| Tax Burden | 10.80 | 1.01 | 0.75 | 2.06 | 0.80 |
| Interest Burden | -19.49 | 1.67 | -0.53 | 0.08 | 0.85 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.39 | 0.18 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.99 | -0.45 | -17.93 | 14.52 | 0.56 |
Currency in USD
